ABT vs COR: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

ABT has stronger fundamentals based on our AI analysis.

ABT
ABBOTT LABORATORIES
BUY
77%
Confidence
VS
COR
Cencora, Inc.
SELL
74%
Confidence

ABT vs COR Fundamental Comparison

Metric ABT COR
Revenue $44.3B $85.9B
Net Income $6.5B $559.6M
Net Margin 14.7% 0.7%
ROE 12.5% 29.3%
ROA 7.5% 0.7%
Current Ratio 1.58x 0.92x
Debt/Equity 0.25x 4.15x
EPS $3.72 $2.87

Green = Better metric | Red = Weaker metric

View Full ABT Analysis →
View Full COR Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

ABT vs AAPL COR vs MSFT ABT vs GOOGL COR vs AMZN

ABT vs COR: Frequently Asked Questions

Is ABT or COR a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), ABT has stronger fundamentals. ABT is rated BUY (77% confidence) while COR is rated SELL (74% confidence). This is not investment advice.

How does ABT compare to COR fundamentally?

ABBOTT LABORATORIES has ROE of 12.5% vs Cencora, Inc.'s 29.3%. Net margins are 14.7% vs 0.7% respectively.

Which stock pays higher dividends, ABT or COR?

ABT has a dividend yield of N/A or no dividend while COR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in ABT or COR for long term?

For long-term investing, consider that ABT has BUY rating with 77% confidence, while COR has SELL rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about ABT vs COR?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABT vs COR, the AI consensus favors ABT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.